Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Sells $151,020.00 in Stock

Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the sale, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. This trade represents a 8.91 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Prestige Consumer Healthcare Price Performance

Shares of NYSE PBH opened at $83.77 on Friday. Prestige Consumer Healthcare Inc. has a twelve month low of $62.35 and a twelve month high of $90.04. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The firm has a 50-day moving average of $81.47 and a two-hundred day moving average of $78.24. The company has a market capitalization of $4.15 billion, a price-to-earnings ratio of 19.62, a PEG ratio of 2.69 and a beta of 0.46.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Prestige Consumer Healthcare

A number of hedge funds have recently modified their holdings of PBH. US Bancorp DE increased its stake in Prestige Consumer Healthcare by 20.3% in the 3rd quarter. US Bancorp DE now owns 3,978 shares of the company’s stock worth $287,000 after purchasing an additional 672 shares in the last quarter. Covestor Ltd boosted its holdings in shares of Prestige Consumer Healthcare by 95.6% in the third quarter. Covestor Ltd now owns 1,338 shares of the company’s stock worth $96,000 after buying an additional 654 shares during the period. Aigen Investment Management LP purchased a new position in shares of Prestige Consumer Healthcare in the third quarter worth approximately $345,000. MQS Management LLC acquired a new stake in shares of Prestige Consumer Healthcare during the third quarter valued at approximately $552,000. Finally, Huntington National Bank lifted its position in shares of Prestige Consumer Healthcare by 39.9% in the 3rd quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after acquiring an additional 181 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently commented on PBH shares. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Sidoti downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a report on Monday, December 9th. Oppenheimer raised their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. Canaccord Genuity Group upped their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Finally, DA Davidson raised their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $92.60.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.